volume 6, issue 2, Pe1000753 2010
DOI: 10.1371/journal.ppat.1000753
View full text
|
Sign up to set email alerts
|
Share

Abstract: Candida albicans, the major fungal pathogen of humans, causes life-threatening infections in immunocompromised individuals. Due to limited available therapy options, this can frequently lead to therapy failure and emergence of drug resistance. To improve current treatment strategies, we have combined comprehensive chemical-genomic screening in Saccharomyces cerevisiae and validation in C. albicans with the goal of identifying compounds that can couple with the fungistatic drug fluconazole to make it fungicida…

Expand abstract